Safety and efficacy of once-weekly basal insulin Fc in people with type 2 diabetes previously treated with basal insulin: a multicentre, open-label, randomised, phase 2 study
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safety and efficacy of once-weekly basal insulin Fc in people with type 2 diabetes previously treated with basal insulin: a multicentre, open-label, randomised, phase 2 study
Authors
Keywords
-
Journal
Lancet Diabetes & Endocrinology
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2023-02-07
DOI
10.1016/s2213-8587(22)00388-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Switching to Once-Weekly Insulin Icodec Versus Once-Daily Insulin Glargine U100 in Type 2 Diabetes Inadequately Controlled on Daily Basal Insulin: A Phase 2 Randomized Controlled Trial
- (2021) Harpreet S. Bajaj et al. DIABETES CARE
- The future of insulin therapy
- (2021) Tim Heise DIABETES RESEARCH AND CLINICAL PRACTICE
- Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial
- (2021) Bernhard Ludvik et al. LANCET
- 237-OR: Insulin Icodec: An Insulin Analog Suited for Once-Weekly Dosing in Type 2 Diabetes
- (2020) ULRIKE HÖVELMANN et al. DIABETES
- Once-Weekly Insulin for Type 2 Diabetes without Previous Insulin Treatment
- (2020) Julio Rosenstock et al. NEW ENGLAND JOURNAL OF MEDICINE
- 2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2019) John B. Buse et al. DIABETOLOGIA
- Clinical Inertia in Type 2 Diabetes Management: Evidence From a Large, Real-World Data Set
- (2018) Kevin M. Pantalone et al. DIABETES CARE
- Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors
- (2016) William Polonsky et al. Patient Preference and Adherence
- Adherence to GLP-1 receptor agonist therapy administered by once-daily or once-weekly injection in patients with type 2 diabetes in Germany
- (2016) Karel Kostev et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- High Incidence of Hypoglycemia in Stable Insulin-Treated Type 2 Diabetes Mellitus: Continuous Glucose Monitoring vs. Self-Monitored Blood Glucose. Observational Prospective Study
- (2015) Marcos Pazos-Couselo et al. Canadian Journal of Diabetes
- Longitudinal Effects of Medication Nonadherence on Glycemic Control
- (2014) Leonard E. Egede et al. ANNALS OF PHARMACOTHERAPY
- The association between nonadherence and glycated hemoglobin among type 2 diabetes patients using basal insulin analogs
- (2014) Marco DiBonaventura et al. Patient Preference and Adherence
- Real-world factors affecting adherence to insulin therapy in patients with Type 1 or Type 2 diabetes mellitus: a systematic review
- (2013) M. J. Davies et al. DIABETIC MEDICINE
- The Impact of Treatment Noncompliance on Mortality in People With Type 2 Diabetes
- (2012) C. J. Currie et al. DIABETES CARE
- Insulin adherence behaviours and barriers in the multinational Global Attitudes of Patients and Physicians in Insulin Therapy study
- (2012) M. Peyrot et al. DIABETIC MEDICINE
- Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study
- (2012) John B Buse et al. LANCET
- Correlates of Insulin Injection Omission
- (2010) M. Peyrot et al. DIABETES CARE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now